- Home
- STRO vs REFI Comparison
STRO vs REFI Comparison
Compare STRO & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STRO | REFI |
|---|---|---|
| Founded | 2003 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.0M | 255.6M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | STRO | REFI |
|---|---|---|
| Price | $11.67 | $12.26 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 1 |
| Target Price | $18.29 | ★ $20.00 |
| AVG Volume (30 Days) | 120.7K | ★ 157.4K |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 16.80% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.69 |
| Revenue | ★ $105,646,000.00 | $54,287,847.00 |
| Revenue This Year | $63.08 | $13.78 |
| Revenue Next Year | N/A | $4.07 |
| P/E Ratio | ★ N/A | $7.24 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.23 | $11.85 |
| 52 Week High | $21.50 | $16.27 |
Technical Indicators
Market Signals| Indicator | STRO | REFI |
|---|---|---|
| Relative Strength Index (RSI) | 77.47 | 38.12 |
| Support Level | $8.49 | $12.15 |
| Resistance Level | $12.18 | $13.20 |
| Average True Range (ATR) | 0.79 | 0.28 |
| MACD | -0.09 | -0.08 |
| Stochastic Oscillator | 78.62 | 7.46 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.